Brief: Akari Therapeutics Appoints Wendy Dicicco As Interim CFO
19/07/2023 13:13
July 19 (Reuters) - Akari Therapeutics PLC AKTX.O :
* AKARI THERAPEUTICS APPOINTS EXPERIENCED LIFE SCIENCES
EXECUTIVE
WENDY DICICCO AS INTERIM CHIEF FINANCIAL OFFICER
Source text for Eikon: ID:nGNX5rtx1S
Further company coverage: AKTX.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Akari Therapeutics
See all newsBrief: Akari Therapeutics - Aktx-101 Demonstrates Robust Anti-Tumor Activity In Urothelial Cancer Preclinical Models
UK's Akari Therapeutics Q2 net loss widens on higher R&D for AKTX-101
Akari Therapeutics PLC reports results for the quarter ended June 30 - Earnings Summary
Akari Therapeutics PLC expected to post a loss of $1.40 a share - Earnings Preview
Brief: Akari Therapeutics Enters Strategic Research Collaboration With Whitehawk Therapeutics